More consistent TIL assessments, more accurate patients' prognoses: New research shows how AI sharpens pathologists' interpretation of tissue samples for malignant melanoma.
Digital pathology software company Fujifilm Healthcare Europe and Ibex Medical Analytics, specializing in AI-powered cancer diagnostics, announce a formal partnership to support efficient and accurate cancer diagnosis.
North Bristol NHS Trust and Fujifilm Healthcare Europe continue their long-standing relationship, with the establishment of a reference site agreement for the company's new pathology solution.
The evolving role of AI tools in digital pathology was explored at an open discussion during the annual Digital Pathology and AI Congress in London with a high-level panel of practitioners looking at current and future technology options. The panel of pathologists, scientists and academics from Europe and the USA assessed the tools they currently use and are available to them, and those they…
Anatomically accurate 3D-printed phantoms for CT imaging and AI training show promise as an alternative to cadavers. The new technology allows for patient-specific phantoms with realistic radiopacity.
Researchers developed an advanced AI tool for automatic analysis of colorectal cancer tissue slides. The new model outperformed all predecessors in the classification of tissue microscopy samples.
Point-of-care diagnostics based on a combination of mobile-sized scanners and artificial intelligence (AI) are helping save the lives of women in low-resource settings. The AI technique is being applied in Kenya and Tanzania to deliver screening for cervical cancer – now the leading cause of cancer-related deaths in women in that region and a bigger cause of death than childbirth.
The installation of a state-of-the-art digital PET/CT scanner in Essen marks the German debut for the technology of United Imaging. The device is designed to deliver precision diagnostics at the Kliniken Essen-Mitte Evang and the private nuclear medicine clinic Nukmed, a premier cancer care institution.
A new study measured how well breast cancer patients’ tumour ‘explants’ respond to chemotherapy or HER2 antibody therapy in the laboratory. This could help improve clinical outcomes.
Complex diseases could require complex biomarkers for accurate diagnosis in the years ahead, according to a leading pathologist. In a keynote address to the 36th European Congress of Pathology in Florence, Italy, Professor Manuel Salto-Tellez highlighted this as one of the major future challenges for the discipline. However, he also believes pathologists will sit at the core of modern medicine.
To advance the transition of AI from research to clinical application, Nvidia announced that Siemens Healthineers has adopted MONAI, an open-source medical imaging framework.
In the world of theatre, the ‘deus ex machina’, the god from the machine, is a dramaturgical trick to resolve seemingly unsolvable conflicts. Can artificial intelligence (AI) also be such a universal problem solver for internal medicine? At the Annual Congress of the German Society of Internal Medicine (DGIM), Dr Isabella Wiest explored the potential – and limitations – of AI helpers.
How can innovations help to master challenges and demands in healthcare? This central question will be addressed at the Medica Health IT Forum, an established part of the programme at the trade fair.
Artificial Intelligence (AI) remains a divisive topic within the discipline of pathology with a range of opinions over its current value and applicability in clinical settings. While most experts agree that the technology will not replace pathologists, it might still spell bad news for those who do not embrace AI in their daily practice. On the other hand, reservations persist about whether…
Multiplex imaging can play a critical role in unravelling the tumour microenvironment. The potential and benefits of the emerging approach – a way to extract information from human tissue samples by visualising many more biomarkers than traditional microscopy – was highlighted in presentations during the 36th European Congress of Pathology in Florence, Italy. Speakers also discussed novel…
The study offers valuable insights into the impact of AI technologies on everyday clinical processes. Above all, however, the study calls for clearly structured future research.
Evidence of the superiority of tomosynthesis for breast cancer detection is stacking up, with new results from a 10-year study further demonstrating the 3D imaging technique's benefits.
Currently, it is difficult to predict whether a cancer patient will respond to immunotherapy or not. A new method to quantify the heterogeneity of the tumour microenvironment aims to improve this.
Cologne researchers have developed an AI-based digital pathology platform to enable extremely fast and accurate fully automated analysis of tissue sections from lung cancer patients.
To diagnose neuroblastoma in children, lengthy scans and anaesthesia are often required. A new PET/CT imaging technique could deliver faster results without sedation for the paediatric patients.
New research shows that the AI large language model ChatGPT can be tailored to provide accurate responses to questions about digital pathology and compile detailed results.
Ductal Carcinoma in Situ (DCIS) often develop into more invasive forms of breast cancer. To predict which DCIS patients are likely to be affected, researchers have developed an analytic AI-based tool.
The IRCCS in Bologna has inaugurated a state-of-the-art integrated PET/CT system. This cutting-edge technology allows for the entire human body to be studied in a single scan, even detecting the smallest tumour cells.
Generalist Medical Artificial Intelligence (GMAI) models pose a significant challenge to current regulatory frameworks. Experts discuss how regulation of these models could work in the future.
Digital pathology can be used to great effect in pharmaceutical research: it can accelerate analyses, give deeper insights into cellular mechanisms, and enable better understanding of their role into clinical development. This potentially offers clearer predictions on how patients may respond to treatment and lead to personalized therapies.
Some year in this decade, AI tools will become ubiquitous within clinical laboratories. AI has the potential to increase the accuracy of laboratory testing and improve the quality and efficiency of operations and service of testing labs.
Researchers work on the first prototype that applies AI to colorectal diagnosis. The prototype achieved a diagnostic acuity of 93.44% and a sensitivity of 99.7% in the detection of high-risk lesions.
‘Next Generation Radiology: Embracing the future and redefining the field of radiology’: In the run-up to the European Congress of Radiology 2024, we spoke with ESR President Professor Carlo Catalano from Rome, Italy, about the meeting’s content and its intriguing theme.
Researchers have unveiled a detailed understanding of immune responses in cancer, potentially paving the way for the development of new therapeutic strategies, the team hopes.
Digital pathology brings benefits for sample management and optimisation, lets pathologists work on samples remotely: The UK Government has now approved the use of the technique for cancer samples.
AI models are highly capable in analysing tissue samples – as long as conditions are lab-perfect. Add a little contamination, however, and diagnostic accuracy goes out the window, a new study shows.
HighlightsSYNAPSE Pathology software is a comprehensive pathology solution, which is vendor-agnostic and can be integrated with Laboratory Information Systems (LIS / LIMS), and digital slide scanners. SYNAPSE Pathology supports LEAN workflow and collaboration. The solution allows pathology departments to move from analogue to digital at their own pace, and facilitates the integration of any…
Bringing digital pathology together with novel multiplexed staining techniques may answer key questions about complex diseases. Pathologist Lukas Marcelis, MD, PhD, believes such combinations of technology will have benefits for clinicians and patients and can help unravel some of the mysteries surrounding a range of conditions.
Machine learning and AI are playing an increasingly important role in medicine and healthcare, and not just since ChatGPT. This is especially true in data-intensive specialties such as radiology, pathology or intensive care. The quality of diagnostics and decision-making via AI, however, does not only depend on a sophisticated algorithm but – crucially – on the quality of the training data.
Centralized review of slides combined with telepathology has opened up the potential for a dramatic reduction in the waiting times for breast cancer patients to start their therapy. Jan Hudecek from the Netherlands Cancer Institute outlined his team’s framework for multi-centre clinical trials with centralized digital pathology review at the 9th Digital Pathology and Artificial Intelligence…
Experts have highlighted how precision pathology using Artificial Intelligence can provide an effective alternative to molecular diagnostics. This, say a team from the Karolinska Institutet (KI) in Stockholm, Sweden, can also offer multiple advantages within a clinical setting and support risk stratification.
With the introduction of digital pathology, the University of Queensland and Sullivan Nicolaides Pathology aim to provide significantly improved tests in terms of cost, quality and speed.
Scientists have designed an AI tool that can rapidly decode a brain tumor’s DNA to determine its molecular identity during surgery — critical information that can guide treatment decisions.
From current mixed reality assistance, technological advances could soon make fully digital autopsies a reality. This could enhance efficiency and legal certainty, and also benefit training.
Researchers at Harvard Medical School developed a new tool that promises to improve the way pathologists see and evaluate a tumor by providing detailed clues about the cancer.
It is crucial that labs can rely on their slides for a seamless – and accurate – diagnosis. With many more commercial instruments focusing on flexibility and choice, these qualities are difficult to separate from subjectivity and complexity.
For patients with human papilloma virus associated oropharynx cancer, assessing the presence of cancer cells beyond the lymph nodes is critical in determining proper treatment.
A new artificial intelligence model could bring much-needed clarity to doctors delivering prognoses and deciding on treatments for patients with colorectal cancer.
Are you looking for a new software solution for your laboratory? Laboratory information systems by Clinisys offer future-proof solutions you can rely on!
Philips is an active participant in the new European Federation for Cancer Images consortium (EUCAIM) – a project launched in the run-up to World Cancer Day 2023.
The Netherlands Cancer Institute (NKI) will deploy a diagnostic platform from digital and computational pathology solutions provider Proscia, the company announced.
Transforming a regional digital pathology network into a national programme across the UK has the potential to save the NHS around £100m a year. Such a network – one that sees a centralised digital pathology image library and archive, as opposed to individual hospitals having their own infrastructure and teams to manage it – can also offer a range of other benefits alongside significant cost…
New research shows the power of artificial intelligence (AI) applied to endometrial carcinoma microscopy images. This could improve diagnosis and treatment of uterine cancer.
AI-based models for multimodality hybrid imaging have the potential to be a potent clinical tool but are currently held back by a lack of transparency and maturity, says Dr Irène Buvat, from the Laboratory of translational Imaging in Oncology, Institute Curie in Paris, France.
The need for breast cancer screening of transgender individuals has been a topic of uncertainty until recently, due to lack of reliable patient data, consensus by radiologists, published research, and recommended guidelines. A 2021 survey of Society of Breast Imaging (SBI) members revealed that ‘breast radiologists differ in their practice and knowledge regarding screening of transgender…
This summer, The European Commission launched I3lung, a new research initiative as a part of Horizon Europe, the EU’s research and innovation program. This research initiative aims to create a cutting-edge, decision-making tool to help clinicians and patients select the best lung cancer treatment based on each patient’s specific needs and circumstances.
New changes made to the timetable for the In vitro Diagnostic Medical Device Regulation (IVDR) across Europe could have a significant impact on manufacturers and users, an expert points out. While the extension of the transition period was a welcome step, other changes which were hoped for remain painfully absent.
With the rise of syndrome-style infections, co-infections and the current antimicrobial resistance challenges, the need for multiplexed diagnostics is now more important than ever.
Deaths from cancer are currently estimated at 10 million each year worldwide. Conventional cancer staging systems aim to categorize patients into different groups with distinct outcomes. ‘However, even within a specific stage, there is often substantial variation in patient outcomes,’ Markus Plass, academic researcher from the Medical University of Graz, Austria, explained to Healthcare in…
Renal cell carcinoma is among the fifteen most common cancers worldwide. Dr Titus Brinker, from the German Cancer Research Center (DKFZ), looked at whether a convolutional neural network (CNN) can extract relevant image features from a typical H&E-stained slide to predict 5-year overall survival.
Imagine a new quality standard that improves the lives of patients and lab professionals in cancer care.
Machine learning and artificial intelligence (AI) have the potential to transform cancer treatment management worldwide. Their ability to rapidly analyse and integrate routinely acquired diverse data will improve the accuracy and effectiveness of precision medical treatments.
Striving to improve the patient’s quality of life after laryngectomy, researchers conducted a study, during which they searched for pathologies in patients’ voices using artificial intelligence (AI).
Patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis may benefit from biopsy of all areas, given the variation of pathologic diagnoses across individuals.
Dark-field radiography uses a part of X-rays that has hardly been considered so far to expand the spectrum of diagnostic imaging. At the ECR Overture, Theresa Urban presented the new method.
An artificial intelligence (AI) model combining four methods of machine learning (ML) to accurately detect thyroid cancer from routine ultrasound image data has been developed by US researchers.
Researchers from Boston University School of Medicine have developed a novel artificial intelligence algorithm to assess digital pathology data.
A combination of digital pathology and quantitative biomarker analysis in the emerging concept of ‘smart’ cytology has a potential role in the detection and diagnosis of cancer.
Reaching out across 15 hospitals and a population of six million people, a network established by the National Pathology Imaging Co-operative (NPIC) is an ambitious move to advance digital pathology in the North of England.
Fujifilm aims to become an entity that can contribute to the advancement of human health by supporting the ongoing transformation in the healthcare industry – as a “One-Stop” solution partner.
Close liaison between pathologists and data scientists is pivotal in the successful introduction of digital pathology and artificial intelligence (AI) into clinical workflows, according to one of France’s leading pioneers in the field.
Fully digitising pathology operations has led to greater efficiency, cost savings, and quicker diagnosis for the Laboratory of Pathology East Netherlands (LabPON).
The future of pathology is digital – for many departments, transformation requires major modifications but promises significant advantages. Professor Catarina Eloy outlines the vital elements.
Despite a five-year transition period for In-vitro Diagnostic Medical Device Regulation (IVDR), experts fear many actors in the field are still not prepared for the regulations coming into force.
Mark Nicholls reports from the National Cancer Research Institute (NCRI) virtual Festival, with four expert speakers discussing the role of liquid biopsy in cancer detection.
Artificial intelligence (AI) is changing our healthcare systems. It can help us detect diseases earlier, improve patient care and reduce healthcare costs. However, there is still a lack of trust, of rules and safety regulations and of broad data pools. How can we use AI successfully in healthcare systems and what role will it play in the future?
Mindray has launched the new MC-80 Automated Digital Cell Morphology Analyzer, a revolutionary cell morphology system that provides more clarity, more intelligence and more productivity for morphological analysis. Combining MC-80, Mindray’s hematology solution will revolutionize the high-end hematology segment.
Digital technology solutions create new opportunities in diagnosis and assessment of renal conditions. With whole slide imaging (WSI), improved workflow and better visualization, such technology already yields a ROI for hospitals and laboratories.
For the Siemens Healthineers team developing new and ever higher performing computed tomographs is daily fare. But when they introduced their most recent CT system an unusual sense of pride was palpable. The photon-counting detector in the new Naeotom Alpha scanner is different from previous models and achieves a level of detail hitherto unknown.
Digitisation offers great opportunities in pathology to work more efficiently and faster. Used correctly, it reduces the workload for both pathologists and laboratory staff.
This year as every year, the very best in global HealthTech will be converging on Dusseldorf for the Medica trade fair. With more than 127 companies attending the event from November 15-18, France will have one of the largest contingents there. Grouped together under the brand umbrella of “French Healthcare”, the French MedTech companies will be presenting their many innovations to industry…
How will digital technology impact healthcare in 2030? If challenges to acceptance and utilisation can be overcome, healthcare providers and patients will benefit significantly, according to physicians participating in a recent online seminar on this topic.
Leading medical XR experts gathered at Shift Medical to discuss developments on the use of immersive technologies in medicine. We interviewed Doctor Egidijus Pelanis of Oslo University Hospital, about applying extended realities in the operating room.
Researchers have leveraged the power of digital pathology and computational modeling to detect and quantify podocytes, a specialized type of cell in the kidney that undergoes damaging changes during early-stage kidney disease.
Roche announced that it has entered an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the development and distribution agreement, the companies will jointly develop an embedded image analysis workflow for pathologists. This workflow will allow PathAI image analysis algorithms to be accessed within Navify Digital Pathology, the cloud…
In recent years, digital pathology has become increasingly recognised as a clinical diagnostic tool and has taken a crucial role in pathology laboratories. One of the early adopters of digital pathology is the Department of Clinical Genetics and Pathology, Office for Medical Services, Region Skåne, a multisite Swedish laboratory which produces over 800,000 histopathology slides per year. The…
Roche announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche’s uPath enterprise software, an application for pathologist workflow. This open environment allows for the secure exchange and flow of data so that pathologists can access advanced algorithms from third…
More than 50 leading digital pathology experts have been lined up for a major conference in London in December looking at all aspects of the field. Speakers will explore latest developments, new trends, challenges, and innovation, as well as the effects of Covid-19 on pathology practice, during the 8th Digital Pathology and AI Congress on December 1 and 2. Artificial intelligence will feature…
Imaging company Lumito has secured a European patent for an instrument and staining reagents based on UCNPs (up-converting nanoparticles) for imaging in scattering materials, such as human tissue. The instrument is intended for use in tissue diagnostics, to provide pathologists visual depictions of tissue samples as an input for making diagnosis. The technology is patented across three global…
Triage HF Plus, highlighted in the BCS conference session ‘Digital Innovation in Cardiology - What's new?’ is a digital heart failure care project that uses a customised algorithm to detect early signs of deterioration in patients with implanted devices. During her presentation ‘Digital solutions to identify worsening heart failure’, consultant cardiologist Dr Fozia Ahmed discussed the…
Digital pathology (DP) is a game-changer in the workflow, functionality and accessibility of a hospital’s pathology department. As pathologists understand the benefits, and the availability of commercial products and systems increase, alongside data transmission and storage costs decreasing, DP deployment in hospitals is accelerating. Pathology informatics expert Anil V Parwani MD PhD discussed…
Cancer informatics and digital pathology provider Inspirata announced that King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust will pilot its Trial Navigator software as part of an evaluation the organisations are conducting into how artificial intelligence based automation can improve the identification and efficiency of matching patients with cancer to early phase…
A researcher at the Technical University of Denmark (DTU) has developed a mathematical model for use in automated image analysis of tissue samples. The model provides the possibility for better and more similar cancer prognosis and treatment.
Artificial intelligence (AI) could match the impact of PACS on radiology. Covid-19 stimulated the development and testing of AI diagnostic-aiding tools in radiology, an unintended consequence of the pandemic. More image data sets have been created to train AI software – an unexpected benefit for radiology research.
Computer models have been standard tools in basic biomedical research for many years. However, around 70 years after the first publication of an ion current model of a nerve cell by Hodgkin & Huxley in 1952, researchers at Graz University of Technology (TU Graz), in collaboration with the Medical University of Graz and the Memorial Sloan Kettering Cancer Center in New York, have finally…
We recently had the pleasure of interviewing Dr. Peter Riegman from Erasmus University. Dr. Riegman is a Molecular Biologist and head of the Erasmus MC Tissue Bank. As an early adopter of digital pathology, Dr. Riegman purchased his first Hamamatsu Photonics whole slide scanner in 2005. It was a NanoZoomer HT, one of Hamamatsu’s very first production units, and it is still in daily use at…
Communities benefit from sharing knowledge and experience among their members. Following a similar principle - called “swarm learning” - an international research team has trained artificial intelligence algorithms to detect blood cancer, lung diseases and Covid-19 in data stored in a decentralized fashion. This approach has advantage over conventional methods since it inherently provides…
Specialist biorepositories are helping advance personalised medicine by supporting the availability of human tissue for research using digital pathology techniques. The pivotal role of the Glasgow Tissue Research Facility (GTRF) in making tissue available to shape new therapies and treatments was outlined in a presentation to the online “Transforming Digital Pathology – Integrating AI to Move…
The pandemic has presented healthcare systems with new challenges, resulting in backlogs of routine screenings and delayed procedures which threaten the health and wellbeing of patients, as well as the ability of facilities to serve their communities. In order to address these widespread issues, we need to ensure that healthcare professionals are able to operate with precision, confidence and…
Royal Philips and Ibex Medical Analytics announced a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide. The combination of Philips digital pathology solution (Philips IntelliSite Pathology Solution) and Ibex’s Galen AI-powered cancer diagnostics platform, currently in clinical use in Europe and the…
Experts from Sweden, Finland and Kenya are using digital microscopy combined with Artificial Intelligence (AI) to deliver a rapid and effective cervical screening service to rural locations in Kenya. The project sees AI and digital diagnostics bridge the gap between low-resource settings and the availability of centralised AI-enhanced expertise and pathology services, located in larger cities in…
The impact of Covid-19 has been devastating; countless lives lost, millions of infections worldwide, health systems overwhelmed and economies rapidly shrinking. Screening, such as for breast or cervical cancer, is an area particularly affected, with numerous appointments delayed.
Improving workflow is one of the major challenges that radiology departments face. The need to be more efficient, deliver timely and effective patient care, and keep an eye on costs are all factors that seem to be ever-present in the modern imaging department. With the added demands of the coronavirus pandemic as radiology departments continue to play a critical role in the fight against…
"Given the rapid transition towards digitisation, digital pathology is now unquestionably the future", reports pathologist Dr Talat Zehra from Pakistan. "However, some pathologists, particularly in underdeveloped countries, are still reluctant to accept its place in their labs. Among their many reasons, some feel that histopathology is a very complex and subjective field and…
Hybrid PET/CT imaging can fully play to its strengths and steer treatment towards more effective procedures for diagnosing prostate cancer. The examination of the specific antigen PSMA with hybrid PET imaging enables treatment monitoring with significantly higher diagnostic accuracy than conventional imaging and therefore, Professor Clemens Cyran believes, will soon become the standard diagnostic…
Medical imaging IT and cybersecurity company Sectra has received an order for its digital pathology solution from Amsterdam UMC in the Netherlands. This follows a recently announced radiology imaging contract. With radiology and pathology in one joint solution, Amsterdam UMC will be able to conveniently share images and information between the two medical specialties, enabling efficient…
Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict how likely the disease is to recur following surgical treatment for prostate cancer. The tool, called RadClip, uses AI algorithms to examine a variety of data, from MRI scans to molecular…
A deep learning model to predict RNA-Seq expression of tumours from whole slide images was among the industry innovations outlined at the 7th Digital Pathology and AI Congress for Europe. Created by French-American start-up Owkin, the detail of how the company’s HE2RNA model provides virtual spatialization of gene expression was detailed to online delegates by senior translational scientist…
A new generation of tissue microarrays are delivering more efficient and time-effective solutions to answering complex clinical and scientific questions. Sitting at the core of this new approach is digital pathology, allowing specific and targeted analysis of small areas of tissue.
It is a simple image of two desks in a hospital pathology department, taken a matter of months apart. But there can be few more vivid images that illustrate the changing world of pathology as the specialty forges ahead into the digital era. The image was taken by Dr Solène-Florence Kammerer-Jacquet during the transition towards digital pathology at Rennes University Hospital in France in the…
Predicting cancer outcome could help with a clinical decision regarding a patient’s treatment. In his keynote speech during the online ‘7th Digital Pathology and AI Congress: Europe’, Johan Lundin, Research Director at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and Professor of Medical Technology at Karolinska Institute, discussed ‘Outcome and…
Telepathology remains number one application for digital pathology, according to expert Professor Liron Pantanowitz, Professor of Pathology and Director of Anatomical Pathology at the University of Michigan. Speaking at the ‘7th Digital Pathology and AI Congress: Europe’, Pantanowitz outlined advances in telepathology, and its enabling access to broader expertise, image sharing and rapid…
The advent of digital pathology is offering a unique opportunity to develop computerized image analysis methods to diagnose disease and predict outcomes for cancer patients from histopathology tissue sections. Such advances can help predict risk of recurrence, disease aggressiveness and long-term survival, according to a leading expert in the field, Professor Anant Madabhushi from Case Western…
Digitisation offers great opportunities in pathology to work more efficiently and faster. Used correctly, it reduces the workload for both pathologists and laboratory staff. Patients receive their findings faster. The prerequisite is a grossing table that seamlessly integrates the digital systems into the work process.
Covid-19 causes characteristic changes in lung tissue visible in CT scans and chest radiographs, known as “ground-glass” opacities. Imaging is now considered a valid alternative, possibly even superior to RT-PCR. ‘This sparked an international debate about the role of CT in the diagnostic work-up of Covid-19,’ said radiologist Professor Cornelia Schäfer-Prokop.
Rather than using techniques separately, researchers have determined that coupling image-based and serum-based biomarkers achieves a higher diagnostic accuracy in detecting stage two liver fibrosis, or above. The study team, from the NAFLD Research Center, University of California at San Diego (UCSD), and colleagues at Yokohama City University in Japan, used magnetic resonance elastography (MRE)…
Hologic, Inc. has announced it has CE Mark for the Faxitron Path+ Specimen Radiography System, the latest addition to the company’s growing portfolio of digital specimen radiography solutions. The Faxitron Path+ system features a superior, high-resolution imaging detector which enables pathologists to image a wide range of specimens of varying sizes, including bone, foetal remains and breast…
Clinical biochemistry laboratories face many daily challenges, including managing high sample workloads, managing clinician requests for novel tests, and generating and reporting out results in a timely fashion. Irrespective of the methodology employed, high quality and reproducible results are imperative since patient diagnosis and treatment plans are based largely on lab results. For this…
A UK biotech laboratory has used mass spectrometry in a new approach to coronavirus testing. MAP Sciences developed a gargle test, which collects samples from the back of the throat, and avoids the unpleasant sensation of the current PCR (polymerase chain reaction) swab tests. From there, the sample is tested for coronavirus using mass spectrometry (MS) with high levels of accuracy.
Experts have identified two distinct immunological and cellular profiles in the lungs of Covid-19 patients which they believe could help define treatment pathways. From some of the earliest Covid-19 autopsies conducted in Europe, Swiss-based researchers have performed integrative digital pathology and transcriptomic analyses of lung tissues of 16 coronavirus patients who died from respiratory…
International medical imaging IT and cybersecurity company Sectra has signed a digital pathology contract with the Norwegian healthcare region Helse Vest RHF. The healthcare region already uses Sectra’s enterprise imaging solution, which will now include digital pathology. The region-wide solution allows Helse Vest to share resources among healthcare providers, and using the same system for…
The academic teaching Karlsruhe Hospital, at the University of Freiburg, is the largest hospital providing tertiary care in the Middle Upper Rhine Valley. Every year, 63,000 in-patients and 180,000 out-patients are treated in the 1,500-bed facility with 50 departments and 30 out-patient clinics. Inevitably, a hospital of this size has a central lab. We spoke with Dr Horst Mayer, managing senior…
The field of AI-enhanced imaging provides radiologists with an unprecedented opportunity to shape patient care, leading Austrian radiologist Katja Pinker-Domenig explained at ECR 2020.
AI in healthcare has been a trending, sometimes head-spinning topic for a few years – and, with the COVID-19 pandemic, clinicians have been presented with a whole new range of AI products that may or may not meet their needs. When it comes to choosing one’s own set of tools, which criteria should prevail?
Xyall BV, a medtech innovator in molecular pathology, has entered into a multi-year, strategic partnership with Motic, a world leader in microscopy and digital pathology systems. Their goal is to develop an automated, high-precision table-top tumour tissue dissection solution for hospital-based molecular pathology laboratories.
From glass slides to the realm of ones and zeros: Digitising pathology offers many benefits to the specialty. Read our information channel for some of the most exciting applications.
New techniques of infrared-based technology are showing strong potential for cost-effective tissue analysis. Peter Gardner, Professor of Analytical and Biomedical Spectroscopy at the University of Manchester, outlined how hyperspectral imaging coupled with sophisticated computer algorithms can identify and grade cancerous tissue, as well as offer an indication of prognosis. The technique, he…
The anatomical pathologist faces a crisis. Public and private labs suffer increasing caseloads, whilst pathologist numbers diminish for various reasons, including greater cancer prevalence associated with aging populations as well as improved cancer screening programs. Precision medicine typically involves more genetic testing and extensive use of immunohistochemistry to classify cancer and…
Spatial analytics offers greater clarity in the assessment of tumours beyond routine microscopic analysis. High-capacity digital image analysis enables new methods of spatial statistics to extract features not immediately distinguishable by visual inspection. These subvisual features reflect complex properties, such as intratumour heterogeneity and have the additional benefit that they can target…
As Artificial Intelligence continues to impact on the development of digital pathology, potential users are still slow to implement key enabling technologies to harness the benefits, according to Dr David McClintock, who will detail critical steps for pathology departments to transition practice from glass (analogue) to digital (whole slide imaging) and embrace AI, to the 6th Digital Pathology…
Hamamatsu Photonics understand the benefits and challenges of whole slide imaging systems. For over 15 years, we have been working to deliver robust and reliable scanners with optimal image quality. Our NanoZoomer whole slide scanner series quickly transform entire histology and cytology glass slides into diagnostic-quality digital images for duplication, annotation, storage, retrieval, and image…
Cancer informatics and digital pathology solution provider Inspirata announced a commercial partnership with Fujifilm. The partnership enables Fujifilm to supply and service Inspirata’s scanner-agnostic, CE IVD digital pathology workflow software globally and with exclusivity in the UK, Italy, Spain, Portugal, Belgium, the Netherlands, and Luxembourg.
In recent years, technological and regulatory advances have made digital pathology a viable alternative to the conventional microscope. The obtention of a digital replica of the traditional glass slide and its use for primary diagnosis has revolutionized pathology and is shaping the future of the discipline. A digital pathology lab uses digital histology slides for routine diagnosis, and these…
Researchers have developed a novel three-dimensional imaging system to diagnose cervical cancer faster, non-invasively and more efficiently than conventional methods.
To answer medical questions that can be applied to a wide patient population, machine learning models rely on large, diverse datasets from a variety of institutions. However, health systems and hospitals are often resistant to sharing patient data, due to legal, privacy, and cultural challenges. An emerging technique called federated learning is a solution to this dilemma, according to a study…
Despite its proximity to China, Taiwan contained COVID-19 successfully, without a lockdown or movement restriction measures introduced elsewhere. With few new cases reported, life almost returned to normal. Behind the scenes, however, efforts have continued to maintain that positive situation.
Following success of telepathology in the eastern region of Quebec, the service is set to be further expanded across its remote areas. There are also moves towards a fully digital service at some sites, to introduce tele-autopsy into remote regions and extend the geographical coverage further across the region. The latest developments were outlined at the Digital Pathology and AI Congress in…
To investigate rare diseases, applying image-based analytics approaches, including the use of deep learning convolutional neural networks (DL-CNNs), can be a major challenge due to great difficulties in acquiring sufficient numbers of cases and associated digital image sets from the small cohorts typically available. To realise algorithms that are both effective and generalisable, conventional…
Hamamatsu Photonics invites you to join us for a panel discussion with pathologist Matthew Hanna, MD and IT Manager Nikolas Stathonikos on Thursday, 9 July at 17:00 CET. In this rapidly evolving healthcare landscape triggered by COVID-19, pathology, and remote diagnosis have been elevated to critical topics. These two experts, representing both the clinical and information technology areas, will…
The coronavirus crisis has accelerated the use of telemedicine in Spain with an increase in virtual consultation and positive impact on workflow. The challenge will be to make these changes permanent, according to a panel of experts who took part in a conference last June in Barcelona. Spanish patients and healthcare professionals have widely accepted virtual consultation as a new alternative to…
A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluated and implemented into clinical practice.
The Norfolk and Norwich University Hospital (NNUH) has taken the first steps towards establishing a digital histopathology service, which will help to improve cancer care. New systems are being introduced to embrace new technology to track specimens, digitise slides and enable clinicians to analyse and report cases digitally on computers.
Tissue biopsy slides stained using hematoxylin and eosin (H&E) dyes are a cornerstone of histopathology, especially for pathologists needing to diagnose and determine the stage of cancers. A research team led by MIT scientists at the Media Lab, in collaboration with clinicians at Stanford University School of Medicine and Harvard Medical School, now shows that digital scans of these biopsy…
Almost five years ago, the plan to implement a wide-ranging digital pathology approach across the Netherlands began to take shape. As more labs across the country acquire digital pathology capability, with steps to create a strong and accessible image repository and a national image exchange platform, one of the project leaders, Professor Katrien Grünberg, offered an update and spoke of some…
Bringing molecular and digital pathology closer together through a more integrative approach can lead to clear advantages for diagnostic and research workflows. During the recent Digital Pathology and AI Congress (London), Professor Viktor Koelzer explored the benefits and paid particular attention to colorectal cancer (CRC).
The COVID-19 pandemic could, over the next year, lead to a 20% rise in the number of deaths from people who have been newly diagnosed with cancer, according to research supported by DATA-CAN. The analysis is the first to focus on the impact of the emergency on mortality rates in people with cancer and uses data from the health records of over 3.5 million patients in England.
Computational pathology has increased applications for diagnosis, prediction of prognosis and therapy response, facilitating the movement of healthcare towards personalised medicine. Coupled with deep learning, such tools are ever more efficient and robust within research and clinical settings. The growing role of computational pathology was highlighted by Professor Andrew Janowczyk at the…
Hamamatsu and KiKo Knowledge Hub Join Inspirata’s Initiative to Offer Free Remote Pathology Solution for Healthcare Institutions Affected by COVID-19. Inspirata gains strategic support in its initiative to allow pathology departments across the world to offer work-from-home opportunities for their pathologists during the COVID-19 pandemic crisis.
Chest X-ray is the first imaging method to diagnose COVID-19 coronavirus infection in Spain, but in the light of new evidence this may change soon, according to Milagros Martí de Gracia, Vice President of the Spanish Society of Radiology (SERAM) and head of the emergency radiology unit at La Paz Hospital in Madrid, one of the hot spots for viral re-production of COVID-19.
Radiology, pathology, medical genetics and laboratory medicine under one roof: many hospitals are toying with the idea of ‘integrated diagnostics’ but it was the medical management at Geneva’s University Hospital that dared to take the first step and consolidate all these diagnostic disciplines in a single organisational unit: The Diagnostic Department. ‘Our long-term vision is a…
Medical imaging IT and cybersecurity company Sectra has signed a digital pathology contract with the Dutch hospital Zuyderland MC. A digital pathology workflow makes it possible to access and share images and information between departments and hospitals. Storing, reviewing and sharing digital pathology images increases efficiency in primary diagnostics and improves cancer care by facilitating…
Researchers at Karolinska Institutet have developed a method based on artificial intelligence for histopathological diagnosis and grading of prostate cancer. The AI-system has the potential to solve one of the bottlenecks in today’s prostate cancer histopathology by providing more accurate diagnosis and better treatment decisions. The study, presented in The Lancet Oncology, shows that the…
A popular proverb in Mandarin goes ‘Hearing something a hundred times is not as good as seeing it once’ (百聞不如一見). Visiting the Taiwan pavilion at this year’s Medica, it’s clear to see that the Bureau of Foreign Trade (MOEA) from Taiwan, together with the Taiwan External Trade Development Council (TAITRA) and its foster companies, have taken this sentiment to heart.
The advent of digital pathology is helping to address some of the challenges surrounding tissue microarrays as they are integrated into the digital workflow, in some ways giving them ‘a new lease of life’, according to Professor Inti Zlobec, who spoke at the Digital Pathology and AI Congress in London last December. As Head of the Translational Research Unit at the Institute of Pathology,…
Fujifilm Medical Systems U.S.A., Inc. will present research and development advancements in Artificial Intelligence (AI) for digital radiography at McCormick Place in Chicago during the 105th scientific assembly and annual meeting of the Radiological Society of North America (RSNA) from December 1 – 6, 2019. "AI has the potential to bring a wealth of advancements to the medical imaging…
Health tech Made in Taiwan is among the mainstays of every MEDICA; this year’s fair is no exception. In co-operation with the Bureau of Foreign Trade (BOFT) of the Taiwanese Ministry of Economics and the Taiwan External Trade Development Council (TAITRA), 20 world-class healthcare companies are demonstrating innovative medical solutions based on national advances in Artificial Intelligence…
The current introduction of instant access to all patient clinical imaging and medical documentation in one picture archiving and communication system (PACS) for use throughout the Princess Alexandra Hospital Trust (PAHT), in Essex, UK, lies in the hands of Imaging Systems Manager and radiographer Stephen Townrow. In 2017, Townrow went to his hospital’s Board with a business case to consolidate…
Artificial Intelligence (AI) is like a huge blanket that can cover anything from innocuous chess computers to robots which, depending on your viewpoint, could save, oppress or obliterate humanity. However, not every jar labelled AI contains AI. So what is intelligence and can it be created artificially, synthesised like a nature-identical flavouring substance?
Amid ever-growing demand for services, significant challenges face the pathology workforce in the years ahead but – there are also good opportunities. With advances in technology and the advent of artificial intelligence as a decision-making support tool, Professor Jo Martin, President Royal College of Pathologists (RCPath) in the UK, believes there remain opportunities for pathology to play a…
Pathology is embracing digitisation just as radiology did over 20 years ago and both specialties are looking at new ways to integrate each other in their workflows. AI could fuel this sparkling alliance, giving it further means to improve cancer treatment.
A pioneering European research project designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to more patients. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) funded by the European Innovative Medicines Initiative 2 Joint undertaking, brings together clinical scientists from international…
Pathologic-radiologic correlation is already utilised in various settings as a tool to assess the interpretive performance of imaging studies and identify radiologic features corresponding to histologic findings. However, correlative assessment is currently limited mainly to the fields of research and quality assurance, and is generally not a routine element of the radiologist or pathologist…
We talked to Dr Annika Blank, Consultant and Lean green belt, about eight-year experience with the concept and optimisation of processes, the implementation of digital pathology and a voice recognition system for patient management. "The biggest and most cost intensive step taken to optimise workflows was the refurbishment of our laboratory, which was completed in 2016. This allowed us to…
Treating physicians need information about the molecular subtype of the tumor if they are to provide targeted therapy for colorectal carcinoma. A research team from University Hospital Zurich and the University of Oxford have now developed a method to predict the molecular classification of colorectal cancer from digital pathology slides.
In view of the advent of personalised medicine and holistic therapy many experts predict the end of healthcare as we know it. However, in many places it is ‘healthcare business as usual’. In our interview, Dr Christoph Zindel, President Diagnostic Imaging at Siemens Healthineers, explains where he sees radiology bridging the gap between symptom-centred treatment today and the systemic…
Image analysis of prostate cancer is a challenging area for clinicians. The disease shows a low mutation burden compared to melanoma and stomach cancer, for example, making morpho-molecular correlation more difficult, and there is often very low inflammation. With the role of tumour infiltrating lymphocytes in prostate cancer currently unclear – and with the advent of new approaches to prostate…
As reporting workload for pathology departments continues to rise rapidly, artificial Intelligence (AI) solutions are set to play an increasing role in daily practice. ‘I see this as the future of digital pathology,’ said histopathologist Professor David Snead at the Digital Pathology and Artificial Intelligence Congress held in London.
A new deep learning algorithm, which demonstrates the potential of artificial Intelligence (AI) to support pathologists, has been developed for PD-L1 scoring in tumour cells and immune cells in urothelial carcinoma samples. Speaking at the Digital Pathology and Artificial Intelligence Congress in London last December, Dr Michel Vandenberghe, from AstraZeneca, outlined how PD-L1 expression level…
Pathologists, radiologists, urologists and radiotherapy specialists sit at the core of the treatment pathway for the patient, working together as a cohesive unit. In an innovative 2019 ECR session in Vienna, the prostate unit from Ghent University Hospital in Belgium outlined how the team works to deliver the best clinical outcome for patients.
Bring your application into the digital world and combine the new Olympus EP50 camera with our wide range of microscopes. Add the accesoires you need and choose the kit that fits your requirements. The Olympus EP50 camera makes digital imaging of microscopy samples a fast and engaging experience and is ready to use in seconds. The EP50 camera adds sophisticated digital features to any microscope…
Digital pathology can gain huge benefits from rapid image search and the effective extraction of knowledge from large medical archives via artificial intelligence (AI). It facilitates identification of anatomical and pathological similarities, significantly enhances the clinical workflow, and ultimately paves the way for more informed diagnosis and better patient outcome. Effective archive…
Digital pathology, combined with the power of Artificial Intelligence (AI), is one of the most promising fields for the delivery of precision medicine. In the first keynote address for the 5th Digital Pathology & AI Congress (Europe) held in London last December, Professor of Pathology, Marilyn Bui, focused on how digital pathology is impacting on precision medicine. During her address,…
AI algorithms are making their way not just into diagnostic workstations, but will also in future be found in the diagnostic methods themselves. Prof. Mathias Goyen, Chief Medical Officer Europe at GE Healthcare, discusses AI algorithms in radiology. "According to a study by the consultancy firm Accenture, the estimated annual market volume for AI applications in healthcare in the USA will…
The topic of artificial intelligence (AI) was omnipresent at RSNA2018, the annual meeting of the Radiological Society of North America. From the opening presidential address, throughout scientific sessions and educational presentations, to the vendors’ technical exhibition, around 53,000 attendees learned about pioneering new products, research, plus challenges and opportunities to implement…
Currently many researchers and experts assume that the next great socio-economic revolution will include a completely new definition of health and how we define illnesses and therapies. “Our health system today can no longer be sustained in its existing form. It has become too expensive and too ineffective,” Professor Harald Schmidt, head of the Department of Pharmacology and Personalised…
Several research groups at Berlin Institute of Health (BIH) are working on digitally combating cancer. The main goal is to combine and jointly evaluate existing information. With 500,000 new cancer cases every year in Germany alone, it is worthwhile comparing experiences with different diagnostic and treatment methods, thus allowing more patients to benefit from the most promising approaches. In…
Researchers have developed a prototype medical device based on silicon photonics for the screening of arterial stiffness and for the diagnosis of cardiovascular diseases such as arterial stenosis and heart failure. This is a cooperation between imec, the world-leading research and innovation hub in nanoelectronics and digital technology and Ghent University, together with Medtronic and other…
The European Society of Pathology (ESP) holds its European Congress of Pathology (ECP) at different venues annually. This year, in Spain, 3,448 delegates from 87 countries attended. There, ESP president Dina Tiniakos spoke about the increasing role of pathology in precision medicine including challenges linked to digitisation. ‘Precision medicine is the centre-point for cancer management, but…
Efforts have been made to digitise pathology in the Netherlands, where the Dutch pathology network PALGA has run since 1990, connecting all of the Netherlands’ laboratories. Paul J van Diest, head of the pathology department at the Utrecht University Medical Centre, presented the brand new Dutch digital pathology platform during ECP 2018. Launched this year, this enables quicker, easier…
Leeds Teaching Hospitals NHS Trust and the University of Leeds have announced a critical milestone in going digital, by scanning every glass slide they produce. The milestone represents a major step towards achieving faster and accurate diagnosis for cancer patients in the future. The Pathology Department, located in St. James’ Hospital in Leeds, is one of the largest in the UK processing over…
Royal Philips has been leading two healthcare innovation projects that will receive government investment as part of major cross-sector collaborations with the NHS, academia and industry partners from the UK Government’s Industrial Strategy Challenge Fund, delivered through United Kingdom Research and Innovation (UKRI). A joint multi-million pound investment by government and industry partners,…
As in many other countries, Belgium faces a significant shortage of health professionals – particularly pathologists to guarantee the diagnostic quality necessary for adequate therapeutic choice. A digital pathology platform can be a true ally; the Brussels Erasmus Hospital opted for that solution. Project manager Dr Ali Ramadhan shared his experience – the good, the bad and the ugly – at…
Hungary has one of the worst outcomes when it comes to cancer. Early detection and accurate diagnosis could significantly reduce the costs of oncological treatment. Pathology plays a crucial role in diagnoses, but is crippled by severe shortage and fragmentation. Digital pathology could help overcome those difficulties – and two projects underway seem particularly fit to help, László Fónyad,…
Let your images tell the story with Olympus’ high-quality digital color cameras for microscopy in hospitals. With crisp, noise-free images and 4K UHD live viewing, the Olympus UC90 and SC180 brightfield cameras capture all the details you see through the oculars – enabling easy on-screen viewing or sharing in large-screen presentations.
When two powerful products are combined, the outcome often becomes much more effective. One such proof is the digital pathology, where technology coupled with medicine. The introduction of technology has completely transformed the face of medical diagnosis, providing new hope to many sufferers. It has become essential to identify the cause of diseases to prevent them in the early stages to avoid…
The benefits of digital pathology have been well-documented along with the need for significant capital investment. Yet, as some pathology networks are discovering, there can be ongoing challenges to bringing an integrated system into play. Path Links – a single managed clinical pathology network operating across Lincolnshire in the east of England – and Nottingham University Hospitals in the…
Machine learning is adding a new dimension to pathology and already outperforming experts during some tasks, according to several speakers at the 14th European Congress on Digital Pathology (ECDP) who revealed up-to-date developments. However, whilst AI is set to herald a new future for digital pathology, Johan Lundin, associated professor for biomedical informatics and research director at the…
Ensure reliable diagnoses in pathology with Olympus’ market-leading LED technology. True Color LED illumination is a durable, bright light source especially designed to closely match halogen illumination, delivering accurate color reproduction every time. The light produced by many LED designs does not allow reliable color distinction in a specimen. In fact, when compared to halogen light…
Recognising malignant tissue remains a tricky task. While today, most patients undergo a biopsy, an invasive procedure where tissue is sampled, stained and assessed, researchers are exploring the potential of optical biopsy, the visual assessment of suspect tissue. The interest in optical biopsy ‘is indeed enormous,’ confirms Dr Thomas Bocklitz, physicist at Friedrich-Schiller University in…
In the next five to 10 years, artificial intelligence is likely to fundamentally transform diagnostic imaging. This will by no means replace radiologists, but rather help to meet the rising demand for imaging examinations, prevent diagnostic errors, and enable sustained productivity increases.
Half of cancers can be avoided if institutions would exchange knowledge, according to Joxel García, executive director of the University of Texas MD Anderson Cancer Center in Houston, who opened the Center’s meeting in Madrid in October 2016. Technology has progressed enormously and there has never been that much knowledge of cancer to prevent it and find treatment tools.
The emerging field of psychoradiology is taking a major step ahead. A new study highlights MRI’s role in identifying people with attention deficit and hyperactivity disorder (ADHD) and classifies subtypes of the condition, a leading Chinese researcher explained at the ESMRMB annual meeting.
GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients. The two companies aim to develop an industry-first digital platform, using advanced analytics…
Cancer surgeons perform an estimated 1.7 breast biopsies each year, according to the American Association of Preferred Provider Organizations. This makes the procedure a significant proportion of cases referred to anatomic pathologists. This surgery, however, is time-consuming and not always accurate due to shortcomings in existing surgical technology and to human error. Now, a 3D-printed…
Professor Jo Martin, the newly-appointed President of the Royal College of Pathologists in the United Kingdom, believes the National Health Service (NHS) is on the brink of embracing digital pathology more widely. A number of UK laboratories, he explained, are adopting digital pathology in histopathology – in line with some labs in Sweden and Holland, where it has become routine – and the…
Digital pathology places particularly high demands on image quality and thus on monitors. Especially the exact colour rendering is a challenge – no other discipline needs such precision for a reliable diagnosis. To that end, following ‘intensive research and development’, JVC Kenwood has launched the JD-C240, a 24.1-inch colour monitor.
The Assistance Publique Hôpitaux de Paris (AP-HP) has organized, in partnership with TeraRecon, Vizua, Microsoft and Digital Evolutis, the live broadcast of the first surgery performed in the world with a collaborative platform of mixed reality at the Avicenne Hospital AP-HP, and interacting with remote doctors. Dr. Gregory Thomas, Head of Orthopedic Surgery and Traumatology Hospital Avicenne…
Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a study presented by Mayo Clinic researchers at the 2017 San Antonio Breast Cancer Symposium. “Our study aimed to compare contrast-enhanced mammography with breast MRI in evaluating residual breast cancer in…
The digital pathology places particularly high demands on the image quality and thus on the monitors. Especially the exact color rendering is a challenge - no other discipline needs such precision for a reliable diagnosis. JVC KENWOOD fully meets these requirements with its new 24.1-inch color monitor JD-C240. "It is the result of intensive research and development work," says Marcel…
Early adoption of image analytical tools and artificial intelligence (AI) are crucial if health systems across Europe are to see the full potential of digital pathology, according to leading expert Professor Johan Lundin, Research Director at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki. Although European institutions increasingly embrace digital pathology, he…
Just as for other medical fields, DICOM is expected to play a significant role in pathology as a universal and fundamental standard in digital medical imaging. The value chain of solution components in a digital pathology lab is both long and complex, which makes the adoption of standards as DICOM all the more important. "One of the visions driving DICOM in general is to give users the…
Neagen and Visiopharm announce an integration which improves the data quality of cancer patient samples in a single PACS-driven digital pathology workflow also offering time and cost savings. This in term enhances quality for pathologists working in cancer research and diagnostics and benefits the patients.
Hamamatsu Photonics introduces the NanoZoomer S360, a new high throughput Whole Slide Imaging scanner, engineered using Hamamatsu Photonics’ extensive experience of imaging technology and designed to meet the challenging requirements of digitizing routine clinical pathology.
A national pathology image exchange platform for The Netherlands is expected to be in place and operational within the next 12 months.
In the nineties Deep Blue, the famous chess computer, defeated Kasparow. Only a year ago Google’s Deepmind managed to master the ancient Chinese Go, known for its utmost complexity.
Digital pathology has been the next big thing for about a decade. Yet, today only a few pathology laboratories are fully equipped to digitise their workflow, mainly for legal or financial reasons.
Among the earliest centres to embrace the concept of digital pathology, the Leeds Digital Pathology Project began in 2003 thanks to a Department of Health grant. Today the centre is Europe’s largest.
Certain members of Generation Y, who grew up alongside enormous information technology (IT) advances, now occupy decision-making roles. Meanwhile, generation Z is emerging into the continuing IT revolution; the digital world surrounds us.
Early adoption of image analytical tools and artificial intelligence are crucial if health systems across Europe are to see the full potential of digital pathology, according to a leading expert. While a growing number of European institutions are beginning to embrace digital pathology, Professor Johan Lundin remains concerned about the slow pace of progress. He acknowledges that more…
As the demand for imaging studies booms and digital pathology takes off, it is becoming necessary to look at the interactions between radiology and pathology in telemedicine, an expert explained during the Radiology Triangle Madrid meeting early this year.
With MEDICA 2017 drawing ever nearer, Joachim Schäfer, Managing Director of Messe Düsseldorf GmbH, sets the stage with the following statement:
Laboratory medicine delivery, regulation and accreditation vary between countries, e.g. Norway, Serbia and France recently aired at FiLM 2017. Leading figures explained the shape, scope and funding of healthcare and lab services and roles played by different professionals and challenges they face.
Royal Philips (NYSE: PHG, AEX: PHIA) and LabPON, the first clinical laboratory to transition to 100% histopathology digital diagnosis, today announced its plans to create a digital database of massive aggregated sets of annotated pathology images and big data utilizing Philips IntelliSite Pathology Solution1. The database will provide pathologists with a wealth of clinical information for the…
When it comes to automation, clinical microbiology has for many years lagged behind other laboratory disciplines. Robotics and computer processing revolutionized chemistry and hematology instruments decades ago. Meanwhile, clinical microbiologists continue to open specimen containers by hand and grow bacteria using methods familiar to microbiology’s founding fathers from the 19th century.
From the extremely new, but not generally available, to the somewhat new… very available and highly useful… Walter Kucharczyk outlines potentials and practicalities in advanced brain tumour Imaging.
An alliance between Siemens Healthineers and IBM Watson Health aims to support service providers in the healthcare system, such as hospitals, health networks and other providers.
Dr Ralf Doyscher, from the Department of Sports Medicine at Charité – Universitätsmedizin Berlin, has a close association with soccer at both professional and amateur levels. He recently participated in a scientific project focusing on preventative check-ups for the general health of elite young soccer players, and took the opportunity to simultaneously investigate the potential of…
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with the organization Pathology Projects (SPP) in the Netherlands to offer all 50 pathology labs in the country to connect to a shared telepathology solution. Sectra’s cloud-based image-sharing solution will enable pathologists to efficiently share digital pathology images on a national scale.…
From the extremely new, but not very available, to the somewhat new, very available and highly useful, Walter Kucharczyk will cover the potentials and practicalities in advanced brain tumor imaging.
Installing a complete diagnostic radiology solution to network six sites of a hospital group, to process, manage and archive image data acquired across all modalities, is a ‘challenge’, acknowledged by Professor Dr Peter Landwehr, Medical Director of the Clinic for Diagnostic and Interventional Radiology of Diakovere Henriettenstift, Hanover, Germany. In 2010, he and his team overcame that…
The ability to digitise results from patient samples has been one of the key enabling technologies that make personalised medicine possible now, says Dr Fiona Carragher, the Deputy Chief Scientific Officer for NHS England.
Visiopharm A/S announces its acquisition of LRI Imaging AB. With more than 10 years of experience in the field, many successful installations in routine diagnostic pathology labs, LRI Imaging AB is the leading diagnostic digital pathology provider in Sweden.
Not having to visit hospital daily, or stay there too long, can improve the lives of patients tremendously. The Vic Hospital Consortium, in Catalonia, Spain, has begun to use a new remote monitoring system that enables it to monitor patients wherever they are. European Hospital spoke with Enrique de la Vega, digital product manager at Catalonia’s technology centre Eurecat, the organisation…
21st century technology has outpaced our expectations. One such example is the invention of advanced digital manufacturing techniques, better known as 3-D printing. Patients and the medical community are yet to see the full implementation of this technology within healthcare.
Pathcore and Visiopharm today announced a partnership to provide enhanced workflow software solutions for quantitative analysis and management of digital pathology images.
International medical imaging IT company Sectra and digital pathology company Visiopharm A/S have reached agreement on an open exchange of pathology images between their respective digital pathology systems. The companies agree that open solutions and the free exchange of information between the various healthcare IT systems without “internal company formats” are of benefit to both customers…
Investing in equipment and systems, training personnel and picking the right manufacturer to deliver a system that meets a hospital’s needs are key factors, according to Dr Peter Riegman, Head of Erasmus MC Tissue Bank at Erasmus MC in Rotterdam.
Advanced computer software underpins a service - coupled with a countrywide database, which enables Denmark’s pathologists to optimise the assessment of patients’ specimens.In turn, the digitisation of the system in recent years has led to significant improvements in pathology services, delivering greater efficiency and advances in patient safety.
Saving time and facilitating analyses, the Olympus UC90 microscope camera maximises information captured from samples with ease and simplicity. Featuring a 1-inch 9 Mpx CCD, the UC90 combines 4K resolution with a large field of view, enabling pathologists to view structures in unprecedented detail and context from a single image.
Healthcare and business professionals as well as scientists consider Big Data a promising technology to advance medical research and patient care. “Big Data analysis allows us to better tailor therapies based on the individual patient’s status, that is to implement personalized healthcare,” says Dominik Bertram, Development Manager at SAP and Head of the development field “Personalized…
Stroke patients will first undergo a CT scan as they enter the hospital. Before any further imaging scan is carried out, the medical team must decide whether they need to intervene intra or extra cranially. ‘Imaging enables you to see which pathology you are dealing with and helps you select patients for either recanalisation or revascularisation or, in some cases, occlusion by embolisation,’…
Research by a team at John Hopkins University (JHU) in Baltimore, USA highlights the patients who are most likely to face lethal arrhythmias. They have developed a personalised 3-D virtual heart that can help predict the risk of sudden cardiac death.
England’s NHS has received an advanced medical imaging and genomic data integration platform from a global healthcare information systems specialist.
In order to be able to properly locate digital pathology in the current discourse on the digitalisation of healthcare, pathology has to be understood as a fundamental diagnostic discipline, above all in oncology. Report: Stefan Kropf
Pathologists have been largely diagnosing disease the same way for the past 100 years, by manually reviewing images under a microscope. But new work suggests that computers can help doctors improve accuracy and significantly change the way cancer and other diseases are diagnosed. A research team from Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS) recently developed…
Carestream Health has been selected to implement the Shared Regional Medical Imaging Services (S-PRIM) project in the Île-de-France, the largest region in France, with 12 million residents, making up 19% of the French population. The S-PRIM project will enable rapid implementation of a shared medical imaging infrastructure to ensure the continuity of basic services, such as migration of…
Professor Klaus Kayser, former Head of the Institute of Pathology at Heidelberg University Hospital’s Thorax Clinic, may be retired but he continues to be a leading figure in his discipline, a visionary, famous for this critical and ‘out of the box’ thinking. During the run-up to the European Congress on Digital Pathology (ECDP), we asked the expert about telemedicine and standards and,…
Whilst digital pathology has the potential to deliver more precise diagnostics, there remain a number of barriers to its widespread implementation.
Carol - I. Geppert MD, from the Institute for Pathology at Erlangen University Hospital, Friedrich Alexander University Erlangen-Nuremberg, debates the impact of digitisation on pathology.
Healthcare is going digital. No doubt about it, Prof. Hufnagl predicts. Information and communication technologies have gone beyond moving data from one place to the other; they are triggering stellar improvements in healthcare: diagnoses are becoming ever more precise, therapies ever more personalised. The extent to which the individual clinical disciplines have progressed in their technological…
Harnessing the potential of digital pathology is taking research into new and more efficient biomarkers to a new level. By combining strategic planning with the latest digital pathology technology, high quality tissue microarrays for biomarker research are being produced.
Histopathologists play key roles in diagnosing disease entities and determining biomarkers related to the prognosis and response to specific therapy of malignant tumours. Report: Bela Molnar
Strictly speaking, digital pathology has not yet resulted in any groundbreaking changes for clinical diagnostics. The conventional light microscope introduced to pathology around 100 years ago continues to be the most important tool for pathologists.
Pathologists in Utrecht step away from the microscope as the first fully digital workflow goes live for primary diagnostics. ‘The whole world wants to stop by and see the show,’ said Paul van Diest MD, who leads the Department of Pathology at the Utrecht University Medical Centre.
As laboratories in Europe shift to systems for digital pathology, they must ensure the technology not only works, but works for them, says Dr Liron Pantanowitz, director of pathology informatics at University of Pittsburgh Medical Center (UPMC).
Though it is the underlying science that drives diagnosis and treatment decisions, pathology is an often overlooked field. As part of the health continuum, as the turning point for treatment, as a new source for research and discovery – in all these ways, the power of pathology has gone unnoticed. However, the industry is slowly coming to realize its potential in transforming care, knows Hans…
In a study of 436 breast cancer cases with 28 years of survival data histo-pathologists from Karolinska Institute, Stockholm, Sweden shows that protein tissue-based biomarker data are at least as good as gene expression assays.
Mobile technology could prove an important catalyst in helping take digital pathology onto a new level in delivering clinical diagnostics.
A UK-based neuropathologist has highlighted how the digitisation of pathology will play a pivotal role in taking patient care on to a new and more efficient level. Speaking in a recent Webinar under the heading The Adoption and Benefits of Digital Pathology for Primary Diagnosis, Dr Daniel du Plessis also noted how the digital era would raise the profile of pathology and ‘bring it out of the…
Compressing and storing digital images in pathology remains technically challenging but there are many options that can both help reduce costs and improve efficiency, a Spanish expert will explain in a dedicated talk during ECDP in Berlin.
The equivalent of HD or Ultra-HD for home television and video is now entering the world of medicine. Although 4K technology with its high-resolution display quality is already used in radiology, there are areas that do not yet benefit from this advanced technology.
Pentax Medical launches a world first for endoscopy, the OPTIVISTA EPK-i7010 Video Processor, featuring both digital and optical enhancements, in the European, Middle Eastern & African (EMEA) markets. This unique enhancement combination provides detailed information for more accurate endoscopic in vivo diagnosis through improved vessel and mucosal pattern characterization.
Since the introduction of targeted therapies in oncology the task of the pathologist has expanded beyond histological diagnostics: today, the pathologist analyses tumour tissue samples to establish a molecular profile with tumour cell characteristics – which in turn become the targets of medication.
Last year, the DMS Group acquired 100% of the capital of AXS Medical, a French start-up specialized in developing diagnostic tools used for spinal pathologies.
One thing is certain in big data discussions: Intelligent machines will change our world considerably. What is less certain is exactly how these changes will look. Although networked data processing offers many opportunities, its development is still in the early stages.